Share

    


Home / Search Results

Search Results

You searched for:

Key findings from three case studies highlight the challenges and triumphs in treating chronic lymphocytic leukemia with oral oncolytics.
The interdisciplinary team at Baptist Health, Miami Cancer Institute evaluated existing processes and leveraged technology to improve oral oncolytic compliance through education, consent, and adherence standards.
Pharmacy informatics can be leveraged to help clinical inpatient pharmacists ensure the safe use of oral oncolytics during a patient’s hospital stay.
Because oral anti-cancer agents are most often administered outside of the clinic setting, it takes a multidisciplinary team to successfully manage these patients and their treatments.
St. Luke’s Cancer Institute, formerly known as Mountain States Tumor Institute, established its medically integrated pharmacy in 2010 to manage patients on oral oncolytics. To improve the workflow in the medically integrated pharmacy and assist busy providers with patient care, St. Luke’s Cancer institute’s pharmacy management team discussed opportunities to expand pharmacist responsibilities, including …
To adequately address patient financial toxicity, institutions must assume responsibility for ensuring that patients understand their insurance coverage and anticipated out-of-pocket expenses. Institutions should also have procedures in place to navigate the pre-certification process and prevent claim denials that may ultimately end up as the patient’s responsibility.
Oral oncolytic agents have several advantages over the parenteral route, including patient convenience, prolonged drug exposure, and non-invasive administration.
The cost of prescription drugs is at the forefront of discussions on healthcare reform. At our recent state oncology society meeting, the topic stimulated discussion about medication reuse and recycling programs
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
Long, written descriptions of chemotherapy and its side effects, particularly when prescribing multiple drugs, are often ignored by patients who are overwhelmed by their cancer diagnosis and treatment. From the perspective of the patients, it was clear that all patients needed basic information regarding chemotherapy, including how to react to different situations while on chemotherapy and specifics …
Faced with the ever-growing cost of oral chemotherapy, our TPRxC team is passionate about securing financial support for our patients.
Storage, handling, and disposal of oral agents; possible drug-drug and drug-food interactions; dosing requirements, a plan for missed doses, a refill process; and more on what your patients need to know about oral agents.
The shift from infused to oral agents has implications for patients and cancer programs. This 2011 ACCC Innovator Award winning program explains its pharmacist-managed approach.
While oncology programs and practices must take into account numerous considerations when ramping up their oral chemotherapy services, this article focuses on one unique and very important role to facilitate this transition: the oral oncology nurse navigator.
Understanding the magnitude and underlying considerations surrounding the multidimensional and controversial issue of cancer drug parity is important for evaluating the value of cancer treatments and the impact of related legislative efforts.